Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?

por Adkins, Elizabeth M, Nicholson, Lindsay, Floyd, David, Ratcliffe, Mark, Chevrou-Severac, Helene
Publicado 2017